A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
Enrolling by invitation · Phase 2
Conditions studied: Graves' Disease
In brief
This is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to evaluate the efficacy and safety of IMVT-1402 in adult participants with GD. Eligible participants will be assigned to 1 of 3 study groups (Groups A, B and C) based on their GD status at the completion of their respective feeder study.
Key facts
- Study ID
- NCT07286006
- Run by
- Immunovant Sciences GmbH
- People needed
- 372
- Starts
- 2026-01-26
- Expected to finish
- 2030-03-01
- Last updated by the study team
- 2026-07-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants who completed Study IMVT-1402-2502 or Study IMVT-1402-2503.
- Other, more specific inclusion criteria are defined in the protocol.
You may not qualify if…
- Have permanently discontinued IMP during the treatment period in the feeder study or have met study stopping criteria at any point up until the end of participation in the feeder study.
Where it is running
- Site Number - 1519 — Phoenix, Arizona, United States
- Site Number - 1530 — Tucson, Arizona, United States
- Site Number - 1510 — Concord, California, United States
- Site Number - 1587 — Huntington Beach, California, United States
- Site Number - 1554 — Los Angeles, California, United States
- Site Number - 1588 — Orange, California, United States
- Site Number - 1559 — San Francisco, California, United States
- Site Number - 1558 — Santa Clarita, California, United States
- Site Number - 1552 — Torrance, California, United States
- Site Number - 1533 — Aurora, Colorado, United States
- Site Number -1514 — Englewood, Colorado, United States
- Site Number - 1516 — Newark, Delaware, United States
- Site Number - 1567 — Washington D.C., District of Columbia, United States
- Site Number - 1556 — Clearwater, Florida, United States
- Site Number - 1522 — Doral, Florida, United States
- Site Number - 1523 — Hialeah, Florida, United States
- Site Number - 1581 — Jacksonville, Florida, United States
- Site Number - 1582 — Jacksonville, Florida, United States
- Site Number - 1505 — Miami, Florida, United States
- Site Number - 1564 — Miami, Florida, United States
- Site Number - 1591 — Miami, Florida, United States
- Site Number - 1590 — Ocoee, Florida, United States
- Site Number - 1508 — Orlando, Florida, United States
- Site Number - 1507 — Port Charlotte, Florida, United States
- Site Number - 1561 — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.